S

SWK Holdings Corp
NASDAQ:SWKH

Watchlist Manager
SWK Holdings Corp
NASDAQ:SWKH
Watchlist
Price: 15.89 USD 4.2% Market Closed
Market Cap: 196.4m USD
Have any thoughts about
SWK Holdings Corp?
Write Note

Net Margin
SWK Holdings Corp

19.8%
Current
36%
Average
14.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
19.8%
=
Net Income
10.6m
/
Revenue
53.6m

Net Margin Across Competitors

Country US
Market Cap 194.9m USD
Net Margin
20%
Country IN
Market Cap 1.9T INR
Net Margin
24%
Country IN
Market Cap 1.6T INR
Net Margin
22%
Country IN
Market Cap 1.3T INR
Net Margin
29%
Country JP
Market Cap 1.9T JPY
Net Margin
9%
Country JP
Market Cap 1.5T JPY
Net Margin
6%
Country CA
Market Cap 12B CAD
Net Margin
18%
Country TW
Market Cap 201.4B TWD
Net Margin
23%
Country IN
Market Cap 498.6B INR
Net Margin
25%
Country IN
Market Cap 412.4B INR
Net Margin
28%
Country JP
Market Cap 731.7B JPY
Net Margin
6%
No Stocks Found

SWK Holdings Corp
Glance View

Market Cap
194.9m USD
Industry
Financial Services

SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.

SWKH Intrinsic Value
18 USD
Undervaluation 12%
Intrinsic Value
Price
S

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
19.8%
=
Net Income
10.6m
/
Revenue
53.6m
What is the Net Margin of SWK Holdings Corp?

Based on SWK Holdings Corp's most recent financial statements, the company has Net Margin of 19.8%.